Computer simulation suggests risk-based breast screening could have benefits

July 6, 2018, Cancer Research UK

When it comes to breast cancer screening, there's a delicate balance between the benefits and harms.

Breast can save lives by picking up breast cancers at an earlier stage, when treatment is more likely to be successful. But it also picks up some cancers that would never have gone on to cause harm. This is called overdiagnosis. At the moment, we can't tell harmless and harmful cancers apart, so all will be offered treatment, meaning many women will be treated unnecessarily.

For each woman whose life is saved by , around three will be diagnosed with a that would have caused any problems.

Scientists are looking for a way to minimise the harms of , tipping the balance towards the benefits. And adapting the NHS breast screening programme based on a woman's risk of breast cancer could do just that, according to new predictions.

Results from a study using computer simulations, published in the journal JAMA Oncology, suggests that only screening women deemed at a 'high risk' of breast cancer could help to reduce unnecessary diagnoses, and would be more affordable for the NHS.

While this is a promising start, the study was run entirely using computer programmes. Researchers used NHS figures to predict the impact of adapting the NHS screening programme to only screen women who meet certain genetic risk criteria.

Professor Fiona Gilbert, a co-author of the study from the University of Cambridge, said: "We need to change the model of delivery of breast screening and recognise that women are individuals with different risks and lifestyles. They should be offered screening tailored to their own profile."

What did the study show?

  • The current NHS breast screening programme invites all women aged 50-69 for a mammogram every three years.
  • Researchers ran computer simulations on a hypothetical group of women. They compared three different approaches to screening:
  • no screening programme
  • the current age-based NHS screening programme
  • a programme that calculated each woman's risk before screening began. Only those deemed to be a 'higher risk' of breast cancer were screened.

The researchers gave each woman a risk score based on their genes as well as their lifestyles. They then tried to predict what might happen if woman at different risks of breast cancer were screened.

Once the numbers were crunched, the team looked for a 'sweet spot' – the scenario that gave the best balance of benefits to harms. They found that not screening around a third of women with the lowest risk of breast cancer was that 'sweet spot'.

Not offering screening to these women could save the NHS money compared to the current screening programme. And there could be 27% fewer overdiagnosed cancers. In this hypothetical situation, screening still saved lives from breast cancer. But the trade-off for less overdiagnosis was that there were 3% more breast cancer deaths.

A long way to go

Factoring risk into breast screening could help to minimise the harms, while maintaining benefits and making screening more cost-effective. But it's early days and there's a lot we still don't know.

Because researchers were modelling a hypothetical situation, they had to make a fair few assumptions. Studies like this are an excellent kicking off point when it comes to improving screening, but the results are merely predictions, and should be taken with a pinch of salt.

The big challenge is how to accurately identify women with a lower risk of breast cancer who might benefit from fewer breast screens in the real world.

Dr. Nora Pashayan, lead author from University College London says that there are over 300 gene variants that increase a woman's risk of , so it may be feasible to create a more targeted screening programme in the future.

"However, we recognise implementing an initiative of this nature raises challenges – not least defining those women deemed low risk and making any screening based on risk acceptable to the public, health professionals and regulators."

For now, its important women who are offered screening understand both the benefits and harms when deciding if they want to take up the offer.

Explore further: Why are women at high breast cancer risk not having supplemental MRI screening?

More information: Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer. JAMA Oncology. DOI: 10.1001/jamaoncol.2018.1901

Related Stories

Why are women at high breast cancer risk not having supplemental MRI screening?

March 19, 2018
Women at high lifetime breast cancer risk might benefit from breast MRI screening in addition to routine mammography, but a new study shows that breast MRI is greatly underutilized even though access is widely available. ...

Screening has had 'little impact' on falling breast cancer deaths in the Netherlands

December 5, 2017
Breast screening in the Netherlands seems to have had a marginal effect on breast cancer mortality over the past 24 years, suggests research in The BMJ today.

Breast screening error—women need reassurance, not misleading statistics

May 7, 2018
On Wednesday, Jeremy Hunt announced that the English breast screening programme had suffered a computer failure, resulting in an estimated 450,000 women not receiving their final breast screening invitation since 2009. This ...

Some women still don't underststand 'overdiagnosis' risk in breast screening

August 28, 2014
A third of women who are given information about the chance of 'overdiagnosis' through the NHS breast screening programme may not fully understand the risks involved, according to research published in the British Journal ...

Making individualized choices about breast cancer screening

May 1, 2018
In a JAMA Insights article, published on May 1 by JAMA, co-authors Keating and Pace summarize the current state of breast cancer screening. The authors note, that despite the fact that the United States Preventive Services ...

UK: 450,000 women missed out on breast cancer test

May 2, 2018
Britain's health minister apologized Wednesday for what he called a "serious failure" that resulted in hundreds of thousands of women in England not being invited to a screening test for breast cancer.

Recommended for you

Week 34 of pregnancy reduces breast cancer risk: study

October 23, 2018
Women's bodies undergo a "striking" change during a specific week of pregnancy that can significantly reduce their risk of developing breast cancer later in life, scientists said Tuesday.

New kind of compound shows early promise against prostate cancer

October 23, 2018
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, a new study finds.

New combination treatment flips the switch on melanoma cells

October 23, 2018
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger—commonly, by breaking the action of a gene called p53 that ...

Desperate & duped? GoFundMe means big bucks for dubious care

October 23, 2018
People seeking dubious, potentially harmful treatment for cancer and other ailments raised nearly $7 million over two years from crowdfunding sites, a study found.

Marker found for condition that causes numerous tumors

October 23, 2018
UT Southwestern researchers have made a major advance in uncovering the biology of how thousands of disfiguring skin tumors occur in patients troubled by a genetic disorder called neurofibromatosis type 1 (NF1). This scientific ...

Urban and rural rates of childhood cancer survival the same, study finds

October 23, 2018
Childhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new study from the Brown School at Washington University in St. Louis.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.